Title: 1) Chief Executive Officer; 2) Adjunct Associate Professor
Company: 1) OBTG; 2) University of California Los Angeles
Location: Los Angeles, California, United States
Cristina Bertolotto, MD, chief executive officer at OBTG and adjunct associate professor at the University of California Los Angeles, has been recognized by Marquis Who’s Who Top Doctors for dedication, achievements, and leadership in medicine, higher education and consulting.
Dr. Bertolotto is a distinguished expert in neuroscience and regenerative medicine. She has been instrumental as the chief executive officer at OBTG since 2019. Her work primarily focuses on performing stem cell treatments and managing therapies for various diseases, with a particular emphasis on neurodegenerative conditions such as amyotrophic lateral sclerosis (ALS), multiple sclerosis (MS), Alzheimer’s, autism and Parkinson’s disease. Dr. Bertolotto’s dedication to improving patient outcomes is evident in her innovative approach, which combines stem cells with specific diets and exercise regimens. Her groundbreaking discovery of pluripotent stem cells in fat tissue has been instrumental in treating these conditions, allowing patients to experience improved quality of life and slowed disease progression.
In addition to her role at OBTG, Dr. Bertolotto has been associated with BH Cellular Medicine since 2024 and has been a consultant in her field since 2012. Her academic contributions have also been noteworthy. Since 1990, Dr. Bertolotto has been an adjunct associate professor IV in the pediatrics department at the University of California Los Angeles (UCLA). She has served in the same capacity within the institution’s David Geffen School of Medicine since 1999. Her extensive teaching career began as an assistant professor I at the school of medicine from 1985 to 1990.
Earlier in Dr. Bertolotto’s career, she excelled as the manager of the technology transfer office and as a research scientist II at Cedars-Sinai Medical Center from 1999 to 2012. During this time, she was also an internal review board member between 2007 and 2010. Among other roles, she worked as a staff research associate III at UCLA from 1996 to 1998 and conducted postgraduate research in neuroscience between 1995 and 1996. Dr. Bertolotto’s foundational research endeavors included roles as a research associate at The House Institute from 1995 to 1998 and an assistant research physiologist in the department of physiology between 1993 and 1995.
Dr. Bertolotto’s academic journey is extensive. She received an MD from the University of the Republic in Montevideo, Uruguay, in 1990, followed by postdoctoral work in neuroscience from the David Geffen School of Medicine at UCLA in 1993. Dr. Bertolotto’s commitment to her field is further demonstrated by her membership in industry-related organizations, such as the Neuroscience Conference and Regenerative Medicine U.S., Brazil, and Mexico.
Beyond her professional achievements, Dr. Bertolotto is actively involved in civic-minded organizations. Most notably, she has been an ambassador to Uruguay for Women’s Entrepreneurship Day since 2015.
Dr. Bertolotto’s dedication to advancing medical science has been recognized with a prestigious Medicine Award for her work on neuroscience and research in Uruguay. She attributes her success to her unwavering dedication and focus. Dr. Bertolotto has known since childhood that she wanted to become a physician and help others, never losing sight of her goals.
Looking ahead, Dr. Bertolotto plans to expand her clinics worldwide to provide stem cell therapy and complementary treatments to more patients across different countries. Her vision is driven by a desire to alleviate pain for patients and their families while ensuring that her years of dedicated study benefit as many individuals as possible.
Contact Dr. Bertolotto:
